Incannex Healthcare Ltd (IXHL) Announces Clinical Trial Update
Incannex Healthcare Ltd (IXHL) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: million, Company
Diseases/Conditions: continued execution, Incannex
Clinical Stage: Phase 2, Phase 2 program
Collaboration: CNS
Updated Timeline: The year 2025
🔬 Clinical Development Pipeline (Incannex Healthcare Ltd):
📋 Incannex Healthcare Ltd (IXHL) - Clinical Trial Update
Filing Date: 2026-01-14
Accepted: 2026-01-14 07:30:53
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (Incannex Healthcare Ltd):
💼 Business Developments:
Structured Data: